| Company Name |
Apex Biotechnology Corp |
||
|
Company Name Abb |
ApexBio |
||
|
TSEC Code |
1733 |
||
|
Securities Market |
Taiwan Exchange Security Corp. |
||
|
Industry |
Biotechnology And Medical Care |
||
|
Operation Cites |
Head quarter: No. 7,Li-Hsin 5th Rd.,Hsinchu Science Park,Hsinchu,Taiwan,ROC Tao Yuan Factory: No. 180,Lane 70,Wuqing Rd.,Dayuan Dist.,Taoyuan City 337,Taiwan Apex Biotechnology SuzhouCorp: Room 403,Building 1,Weixin Road,SIP,Suzhou,China Omnis Health LLC: 1309 Elm Hill Pike, Nashville, TN 37210 ,USA |
||
|
Established Date |
12/02/1997 |
||
|
Public Date |
6/13/2000 (4101 Taipai Exchange); 9/17/2001(1733 TSEC) |
||
|
Capital |
NTD 997 Million |
||
|
Chairman/CEO |
Dr. Thomas Y.S. Shen |
||
|
Employees |
738 (12/31/2018) |
||
|
Main Products
|
Glucose monitoring systems Uric Acid monitoring systems Lactate monitoring system Hemoglobin monitoring system Cholesterol monitoring system Hemoglobin A1C POC system Pesticide residues quick check systems Care management and Tele-health |
||
|
Annual Revenue |
2016 |
2017 |
2018 |
|
NTD 1.76 Billion |
NTD 1.79 Billion |
NTD 2.04 Billion |
|
| Year | Q1 | Q2 | Q3 | Q4 |
| 2022 |
|
|
||
| 2022 | Consolidated Revenue (NT Thousand) | |||||
| Revenue | Previous Year | MOM(%) | Year To Date | Last Year To Date | YOY(%) | |
| Jan | 161,017 | 191,093 | -18.77% | 161,017 | 191,093 | -15.74% |
| Feb | 185,661 | 210,250 | 15.31% | 346,678 | 401,343 | -13.62% |
| Mar | 175,276 | 175,045 | -5.59% | 521,954 | 576,388 | -9.44% |
| Apr | 208,187 | 157,667 | 18.78% | 730,141 | 734,055 | -0.53% |
| May | 211,675 | 170,873 | 1.68% | 941,816 | 904,928 | 4.08% |
| Jun | 188,243 | 155,945 | -11.07% | 1,130,059 | 1,060,873 | 6.52% |
| Jul | 203,389 | 172,367 | 8.05% | 1,333,448 | 1,233,240 | 8.13% |
| Aug | 198,847 | 169,558 | -2.23% | 1,532,295 | 1,402,798 | 9.23% |
| Sep | 203,242 | 167,544 | 2.21% | 1,735,537 | 1,570,342 | 10.52% |
| Oct | 162,460 | 165,110 | -20.07% | 1,897,997 | 1,735,452 | 9.37% |
| Nov | ||||||
| Dec | ||||||
| Total | 1,897,997 | 2,131,656 | ||||
Accept
Reject
